Figure 1From: Case analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenib The tumor shrank step by step during early sorafenib treatment. (a) Before targeted therapy, tumor size was 7.7 cm × 7.9 cm × 6.3 cm; (b) week 5 of targeted therapy, tumor size decreased by 39.8%; (c) week 15 of targeted therapy, tumor size decreased by 96.9%.Back to article page